PRENATAL DIAGNOSIS OF CONGENITAL ADRENAL HYPERPLASIA (21-HYDROXYLASE DEFICIENCY) BY HLA TYPING

M. S. Pollack, L. S. Levine, S. Pang, R. P. Owens, H. M. Nitowsky, B. Dupont, D. Maurer, M. I. New, M. Duchon, Irwin R. Merkatz, G. Sachs

Research output: Contribution to journalArticle

79 Citations (Scopus)

Abstract

Congenital adrenal hyperplasia (C.A.H.) due to 21-hydroxylase deficiency is an HLA-linked recessive disorder. HLA-A and B antigens are expressed on amniotic cells. Prenatal diagnosis of C.A.H. by HLA typing of families and amniotic cells was attempted in two at-risk families. In one family HLA typing indicated that the fetus would have C.A.H., and this prediction was confirmed after birth. In the second family, HLA typing indicated that the fetus would be an unaffected, phenotypically normal carrier of the disease gene, and this prediction was also confirmed after birth.

Original languageEnglish (US)
Pages (from-to)1107-1108
Number of pages2
JournalThe Lancet
Volume313
Issue number8126
DOIs
StatePublished - May 26 1979

Fingerprint

Congenital Adrenal Hyperplasia
Histocompatibility Testing
Prenatal Diagnosis
Fetus
Parturition
HLA-A Antigens
HLA-B Antigens
Genes
Congenital adrenal hyperplasia due to 21 hydroxylase deficiency

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Pollack, M. S., Levine, L. S., Pang, S., Owens, R. P., Nitowsky, H. M., Dupont, B., ... Sachs, G. (1979). PRENATAL DIAGNOSIS OF CONGENITAL ADRENAL HYPERPLASIA (21-HYDROXYLASE DEFICIENCY) BY HLA TYPING. The Lancet, 313(8126), 1107-1108. https://doi.org/10.1016/S0140-6736(79)91789-6

PRENATAL DIAGNOSIS OF CONGENITAL ADRENAL HYPERPLASIA (21-HYDROXYLASE DEFICIENCY) BY HLA TYPING. / Pollack, M. S.; Levine, L. S.; Pang, S.; Owens, R. P.; Nitowsky, H. M.; Dupont, B.; Maurer, D.; New, M. I.; Duchon, M.; Merkatz, Irwin R.; Sachs, G.

In: The Lancet, Vol. 313, No. 8126, 26.05.1979, p. 1107-1108.

Research output: Contribution to journalArticle

Pollack, MS, Levine, LS, Pang, S, Owens, RP, Nitowsky, HM, Dupont, B, Maurer, D, New, MI, Duchon, M, Merkatz, IR & Sachs, G 1979, 'PRENATAL DIAGNOSIS OF CONGENITAL ADRENAL HYPERPLASIA (21-HYDROXYLASE DEFICIENCY) BY HLA TYPING', The Lancet, vol. 313, no. 8126, pp. 1107-1108. https://doi.org/10.1016/S0140-6736(79)91789-6
Pollack MS, Levine LS, Pang S, Owens RP, Nitowsky HM, Dupont B et al. PRENATAL DIAGNOSIS OF CONGENITAL ADRENAL HYPERPLASIA (21-HYDROXYLASE DEFICIENCY) BY HLA TYPING. The Lancet. 1979 May 26;313(8126):1107-1108. https://doi.org/10.1016/S0140-6736(79)91789-6
Pollack, M. S. ; Levine, L. S. ; Pang, S. ; Owens, R. P. ; Nitowsky, H. M. ; Dupont, B. ; Maurer, D. ; New, M. I. ; Duchon, M. ; Merkatz, Irwin R. ; Sachs, G. / PRENATAL DIAGNOSIS OF CONGENITAL ADRENAL HYPERPLASIA (21-HYDROXYLASE DEFICIENCY) BY HLA TYPING. In: The Lancet. 1979 ; Vol. 313, No. 8126. pp. 1107-1108.
@article{a4198d82f2fd440d9866bd249be67492,
title = "PRENATAL DIAGNOSIS OF CONGENITAL ADRENAL HYPERPLASIA (21-HYDROXYLASE DEFICIENCY) BY HLA TYPING",
abstract = "Congenital adrenal hyperplasia (C.A.H.) due to 21-hydroxylase deficiency is an HLA-linked recessive disorder. HLA-A and B antigens are expressed on amniotic cells. Prenatal diagnosis of C.A.H. by HLA typing of families and amniotic cells was attempted in two at-risk families. In one family HLA typing indicated that the fetus would have C.A.H., and this prediction was confirmed after birth. In the second family, HLA typing indicated that the fetus would be an unaffected, phenotypically normal carrier of the disease gene, and this prediction was also confirmed after birth.",
author = "Pollack, {M. S.} and Levine, {L. S.} and S. Pang and Owens, {R. P.} and Nitowsky, {H. M.} and B. Dupont and D. Maurer and New, {M. I.} and M. Duchon and Merkatz, {Irwin R.} and G. Sachs",
year = "1979",
month = "5",
day = "26",
doi = "10.1016/S0140-6736(79)91789-6",
language = "English (US)",
volume = "313",
pages = "1107--1108",
journal = "The Lancet",
issn = "0140-6736",
publisher = "Elsevier Limited",
number = "8126",

}

TY - JOUR

T1 - PRENATAL DIAGNOSIS OF CONGENITAL ADRENAL HYPERPLASIA (21-HYDROXYLASE DEFICIENCY) BY HLA TYPING

AU - Pollack, M. S.

AU - Levine, L. S.

AU - Pang, S.

AU - Owens, R. P.

AU - Nitowsky, H. M.

AU - Dupont, B.

AU - Maurer, D.

AU - New, M. I.

AU - Duchon, M.

AU - Merkatz, Irwin R.

AU - Sachs, G.

PY - 1979/5/26

Y1 - 1979/5/26

N2 - Congenital adrenal hyperplasia (C.A.H.) due to 21-hydroxylase deficiency is an HLA-linked recessive disorder. HLA-A and B antigens are expressed on amniotic cells. Prenatal diagnosis of C.A.H. by HLA typing of families and amniotic cells was attempted in two at-risk families. In one family HLA typing indicated that the fetus would have C.A.H., and this prediction was confirmed after birth. In the second family, HLA typing indicated that the fetus would be an unaffected, phenotypically normal carrier of the disease gene, and this prediction was also confirmed after birth.

AB - Congenital adrenal hyperplasia (C.A.H.) due to 21-hydroxylase deficiency is an HLA-linked recessive disorder. HLA-A and B antigens are expressed on amniotic cells. Prenatal diagnosis of C.A.H. by HLA typing of families and amniotic cells was attempted in two at-risk families. In one family HLA typing indicated that the fetus would have C.A.H., and this prediction was confirmed after birth. In the second family, HLA typing indicated that the fetus would be an unaffected, phenotypically normal carrier of the disease gene, and this prediction was also confirmed after birth.

UR - http://www.scopus.com/inward/record.url?scp=0018746735&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0018746735&partnerID=8YFLogxK

U2 - 10.1016/S0140-6736(79)91789-6

DO - 10.1016/S0140-6736(79)91789-6

M3 - Article

VL - 313

SP - 1107

EP - 1108

JO - The Lancet

JF - The Lancet

SN - 0140-6736

IS - 8126

ER -